Fluticasone/Formoterol Mundipharma 250/10 µg Druckgasinhalation, Suspension
Country: Switzerland
Language: French
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Patient Information leaflet
(PIL)
30-05-2024
Summary of Product characteristics
(SPC)
30-05-2024
Active ingredient:
fluticasoni propionas, formoteroli fumaras dihydricus
Available from:
Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch
ATC code:
R03AK11
INN (International Name):
fluticasoni propionas, formoteroli fumaras dihydricus
Pharmaceutical form:
Druckgasinhalation, Suspension
Composition:
fluticasoni propionas 250 µg pro dosi, formoteroli fumaras dihydricus 10 µg pro dosi, natrii cromoglicas, ethanolum 1 mg, apafluranum ad aerosolum, doses pro vase 120.
Class:
B
Therapeutic group:
Synthetika
Therapeutic area:
L'asthme bronchiale
Authorization status:
zugelassen
Authorization date:
2023-12-05
Patient Information leaflet
•
Recherche
•
Recherche SAI
•
Nouveaux textes
•
Textes modifiés
•
Télécharger
•
Aide
•
Se connecter
FR
DE
IT
EN
AIPS - RECHERCHE INDIVIDUELLE
ElViS: le portail de vigilance et d’annonce électronique
Aucun résultat
Read the complete document
